We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Blood Sample Collection Cards Used for Screening Newborns

By LabMedica International staff writers
Posted on 07 May 2009
Dried blood spot cards are used to collect and transport blood specimens from newborns, which are later analyzed by public health laboratories. More...
Newborn screening is used to detect congenital disorders, many of which are treatable only when identified during the first days of life. A significant number of these are treatable when detected, but fatal when not.

PerkinElmer, Inc. (Waltham, MA, USA) has entered into a contract with ID Biological Systems (Greenville, South Carolina, USA) to become its exclusive, worldwide distributor for dried blood spot specimen collection cards used by newborn screening programs worldwide. The agreement is intended to deliver a consistent, high-quality supply of sample collection cards designed to customer specifications.

ID Biological Systems will produce the cards using Ahlstrom grade 226 filter paper. They are manufactured according to the Clinical and Laboratory Standards Institute (CLSI) standard for blood collection on filter paper for newborn screening programs. The paper has been successfully tested to the CLSI standard by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) Newborn Screening Quality program and other third party testing facilities.

"To secure the supply and delivery of U.S. Food and Drug Administration (FDA; Rockville, MD, USA)-approved high quality specimen cards is a priority for PerkinElmer and our newborn screening customers," said Ann-Christine Sundell, president, genetic screening, PerkinElmer. "This agreement expands our offering with a high quality product, and provides IDB Systems with a strong and proven distribution channel for its product."

Gary Resler, health services consultant for the Newborn Screening Program in the State of Washington has been using ID Biological Systems' specimen collection cards for samples processed in his laboratory for the past nine months. "A consistent supply of high quality sample cards is an imperative in a public health laboratory processing hundreds of neonatal samples each day," said Mr. Resler. "ID Biological Systems has delivered this quality and consistency along with a tremendous level of service."

Related Links:

PerkinElmer, Inc.
ID Biological Systems
U.S. Centers for Disease Control and Prevention
U.S. Food and Drug Administration



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
Chromogenic Culture System
InTray™ COLOREX™ ECC
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The model estimated about a fivefold return in gastric cancer prevention benefits per unit invested, with cost-effectiveness maintained in higher-cost settings (Image credit: Adobe Stock)

H. pylori Screening Within Colorectal Program Aids Gastric Cancer Prevention

Health systems increasingly rely on economic evidence to guide cancer prevention strategies. For gastric cancer, selecting screening approaches that can integrate with existing programs is a key policy question.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.